Mozobil used for transplan patients
Ended Awarded
- Contract number
- VA26014F1915
- Awardee
-
Genzyme Corporation UEI X2XMAQLR9DA8
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $20,843
Award facts
- Contract value 100% obligated
- $20,842.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Cambridge, MA 02142, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract VA26014F1915?
VA26014F1915 was awarded to Genzyme Corporation by Veterans Integrated Service Network 20 (Veterans Health Administration) on March 14, 2014.
How much is contract VA26014F1915 worth?
The government has obligated $20,843 on VA26014F1915.
Is contract VA26014F1915 an order under another contract?
Yes. VA26014F1915 is a delivery order under V797P2086D, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract VA26014F1915 competed?
The extent of competition for VA26014F1915 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award